The C4EB study—Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study
Abstract Patients with the genetic blistering skin condition epidermolysis bullosa (EB) report severe pain as a consequence of skin and…